{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:09:39Z","timestamp":1791544179863,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M744024"],"award-info":[{"award-number":["2023M744024"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M734015"],"award-info":[{"award-number":["2023M734015"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110952"],"award-info":[{"award-number":["2023A1515110952"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["No.A2023077"],"award-info":[{"award-number":["No.A2023077"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273204"],"award-info":[{"award-number":["82273204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972471"],"award-info":[{"award-number":["81972471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cpt.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T23:04:39Z","timestamp":1727391879000},"page":"253-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1340-9561","authenticated-orcid":false,"given":"Xingbin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2024.09.006_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2024.09.006_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2024.09.006_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cpt.2024.09.006_bib4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target","volume":"19","author":"Gravalos","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cpt.2024.09.006_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.08.2296","article-title":"LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer\/gastroesophageal junction cancer (GC\/GEJC)\/esophageal adenocarcinoma (EAC): first results of the CheckMate 649 study","author":"Moehler","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cpt.2024.09.006_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cpt.2024.09.006_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol"},{"key":"10.1016\/j.cpt.2024.09.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.cpt.2024.09.006_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12935-023-03169-1","article-title":"The emerging role of glycolysis and immune evasion in gastric cancer","volume":"23","author":"Zheng","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.cpt.2024.09.006_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","article-title":"Metabolic hallmarks of tumor and immune cells in the tumor microenvironment","volume":"8","author":"Renner","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2024.09.006_bib11","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1128\/JVI.01457-07","article-title":"Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus","volume":"81","author":"Zheng","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cpt.2024.09.006_bib12","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5425","article-title":"Claudin-9 is a novel prognostic biomarker for endometrial cancer","volume":"61","author":"Endo","year":"2022","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cpt.2024.09.006_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5152\/tjg.2019.18513","article-title":"Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2\/Stat 3 signaling","volume":"30","author":"Liu","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.cpt.2024.09.006_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10585-015-9776-4","article-title":"A\u00a0spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis","volume":"33","author":"Sharma","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.cpt.2024.09.006_bib15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/onc.2016.289","article-title":"The role of claudins in cancer metastasis","volume":"36","author":"Tabari\u00e8s","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cpt.2024.09.006_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.cpt.2024.09.006_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cpt.2024.09.006_bib18","first-page":"7818","article-title":"Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer","volume":"16","author":"Ouyang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cpt.2024.09.006_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response","volume":"22","author":"Hu","year":"2021","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.cpt.2024.09.006_bib20","article-title":"Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing","volume":"5","author":"Yu","year":"2024","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.cpt.2024.09.006_bib21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1186\/s12885-023-11673-w","article-title":"Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cpt.2024.09.006_bib22","article-title":"Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpt.2024.09.006_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/cac2.12459","article-title":"Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer","volume":"43","author":"Hu","year":"2023","journal-title":"Cancer Commun"},{"key":"10.1016\/j.cpt.2024.09.006_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/beta-catenin signalings activate HIF-1 alpha-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.cpt.2024.09.006_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cpt.2024.09.006_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cpt.2024.09.006_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/cancers14020290","article-title":"Claudins and gastric cancer: an overview","volume":"14","author":"Hashimoto","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2024.09.006_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cpt.2024.09.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07357907.2010.512594","article-title":"Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate","volume":"29","author":"Zavala-Zendejas","year":"2011","journal-title":"Cancer Invest"},{"key":"10.1016\/j.cpt.2024.09.006_bib30","doi-asserted-by":"crossref","first-page":"25828","DOI":"10.18632\/aging.104206","article-title":"A\u00a0glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma","volume":"12","author":"Kang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cpt.2024.09.006_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12935-019-1001-0","article-title":"Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.cpt.2024.09.006_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neo.2017.02.006","article-title":"Identifying regulatory posttranslational modifications of PD-L1: a focus on monoubiquitinaton","volume":"19","author":"Horita","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.cpt.2024.09.006_bib33","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1158\/0008-5472.CAN-18-1892","article-title":"Posttranslational modifications of PD-L1 and their applications in cancer therapy","volume":"78","author":"Hsu","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpt.2024.09.006_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13046-024-02943-x","article-title":"Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression","volume":"43","author":"Meng","year":"2024","journal-title":"J\u00a0Exp Clin Cancer Res"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:25:37Z","timestamp":1746077137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713224000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2949713224000855"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2024.09.006","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}